A kettős antitrombotikus kezelés (kis dózisú rivaroxaban + aszpirin) helye a terápiában A Magyar Angiológiai és Érsebészeti Társaság (MAÉT), a Magyar Kardiológusok Társasága (MKT) és a Magyar Stroke Társaság (MST) közös konszenzusdokumentuma [The role of dual antithrombotic strategy (low-dose rivaroxaban + aspirin) in therapy: Joint consensus document of the Hungarian Society of Angiology and Vascular Surgery (MAÉT), the Hungarian Society of Cardiology (MKT) and the Hungarian Stroke Society (MST)] /

Every second person in Hungary dies because of cardiovascular disease. Cardiovascular (CV) disease and mortality are more common in patients who have already had a CV event. Thus, secondary prevention treatment is of paramount importance in improving morbidity and mortality indicators in Hungary. On...

Teljes leírás